Volume 67, Issue 1, Pages (January 2005)

Slides:



Advertisements
Similar presentations
Volume 124, Issue 7, Pages (June 2003)
Advertisements

Volume 57, Issue 3, Pages (March 2000)
Fig. 2. Effect of Ang II on apoptosis with CaMKII oxidation
Harald D. Rupprecht, M.D, Yoshitaka Akagi, Annette Keil, Gerhard Hofer 
Volume 75, Issue 6, Pages (March 2009)
Tocotrienols Induce Apoptosis and Autophagy in Rat Pancreatic Stellate Cells Through the Mitochondrial Death Pathway  Mariana Rickmann, Eva C. Vaquero,
Volume 57, Issue 3, Pages (March 2000)
Volume 71, Issue 9, Pages (May 2007)
Darren J. Bridgewater, Jackie Ho, Victor Sauro, Douglas G. Matsell 
Volume 79, Issue 2, Pages (January 2011)
Testosterone promotes apoptotic damage in human renal tubular cells
S. Shastry, A.J. Ingram, J.W. Scholey, L.R. James  Kidney International 
Volume 68, Issue 2, Pages (August 2005)
Volume 82, Issue 11, Pages (December 2012)
Cathepsin-B-dependent apoptosis triggered by antithymocyte globulins: a novel mechanism of T-cell depletion by Marie-Cécile Michallet, Frederic Saltel,
Volume 72, Issue 4, Pages (August 2007)
Volume 69, Issue 8, Pages (April 2006)
Volume 96, Issue 10, Pages (May 2009)
John F. Öhd, Katarina Wikström, Anita Sjölander  Gastroenterology 
Volume 55, Issue 6, Pages (June 1999)
Volume 65, Issue 2, Pages (February 2004)
Volume 69, Issue 12, Pages (June 2006)
Volume 63, Issue 3, Pages (March 2003)
Morphogenesis during mouse embryonic kidney explant culture
M.H.A. Baccora, P. Cortes, C. Hassett, D.W. Taube, J. Yee 
Volume 67, Issue 2, Pages (February 2005)
Lipids up-regulate uncoupling protein 2 expression in rat hepatocytes
Epidermal growth factor receptor inhibition attenuates early kidney enlargement in experimental diabetes  Lesley Wassef, Darren J. Kelly, Richard E. Gilbert 
Volume 64, Issue 5, Pages (November 2003)
Cytochrome P450 2E1 null mice provide novel protection against cisplatin-induced nephrotoxicity and apoptosis  Hua Liu, Radhakrishna Baliga  Kidney International 
Volume 73, Issue 5, Pages (March 2008)
Volume 134, Issue 3, Pages (March 2008)
Akio Horiguchi, Mototsugu Oya, Ken Marumo, Masaru Murai 
Volume 62, Issue 3, Pages (September 2002)
Autophagy in proximal tubules protects against acute kidney injury
Inhibition of glomerular cell apoptosis by heparin
BV6, an IAP Antagonist, Activates Apoptosis and Enhances Radiosensitization of Non- small Cell Lung Carcinoma In Vitro  Wenyan Li, MD, PhD, Bo Li, MD,
Volume 63, Issue 3, Pages (March 2003)
Evidence that bone morphogenetic protein 4 has multiple biological functions during kidney and urinary tract development  Yoichi Miyazaki, Keisuke Oshima,
Volume 63, Issue 2, Pages (February 2003)
Volume 65, Issue 3, Pages (March 2004)
Volume 82, Issue 7, Pages (October 2012)
PPARα agonist fenofibrate improves diabetic nephropathy in db/db mice
Volume 64, Issue 6, Pages (December 2003)
Harald D. Rupprecht, M.D, Yoshitaka Akagi, Annette Keil, Gerhard Hofer 
Volume 66, Issue 6, Pages (December 2004)
A JNK-Dependent Pathway Is Required for TNFα-Induced Apoptosis
Tight blood pressure control decreases apoptosis during renal damage
Volume 77, Issue 4, Pages (February 2010)
Volume 73, Issue 5, Pages (March 2008)
Death Receptor-Independent Apoptosis in Malignant Melanoma Induced by the Small- Molecule Immune Response Modifier Imiquimod  Michael P. Schön, B. Gregor.
Volume 68, Issue 2, Pages (August 2005)
Volume 57, Issue 3, Pages (March 2000)
Apoptotic insults to human HepG2 cells induced by S-(+)-ketamine occurs through activation of a Bax-mitochondria-caspase protease pathway  S.-T. Lee,
Volume 79, Issue 4, Pages (February 2011)
Volume 53, Issue 4, Pages (April 1998)
Volume 61, Issue 5, Pages (May 2002)
The pathological role of Bax in cisplatin nephrotoxicity
Yoshihisa Ishikawa, Masanori Kitamura  Kidney International 
Volume 65, Issue 6, Pages (June 2004)
tRNA Binds to Cytochrome c and Inhibits Caspase Activation
Volume 63, Issue 5, Pages (May 2003)
Tumor necrosis factor-α and lipopolysaccharide induce apoptotic cell death in bovine glomerular endothelial cells  Udo K. Meßmer, Verena A. Briner, Josef.
Angiotensin II stimulates Pax-2 in rat kidney proximal tubular cells: Impact on proliferation and apoptosis  Shao-Ling Zhang, Jun Guo, Babak Moini, Julie.
Volume 61, Issue 4, Pages (April 2002)
Volume 54, Issue 4, Pages (October 1998)
Volume 56, Issue 6, Pages (December 1999)
Volume 72, Issue 2, Pages (July 2007)
Differential effects of simvastatin on mesangial cells
by Xuefang Cao, Xingming Deng, and W. Stratford May
Presentation transcript:

Volume 67, Issue 1, Pages 82-93 (January 2005) High glucose evokes an intrinsic proapoptotic signaling pathway in mesangial cells  Rangnath Mishra, Steven N. Emancipator, Timothy Kern, Michael S. Simonson  Kidney International  Volume 67, Issue 1, Pages 82-93 (January 2005) DOI: 10.1111/j.1523-1755.2005.00058.x Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 1 Cytotoxicity and apoptosis in human mesangial cells treated with high glucose. (A) Human mesangial cells were plated in Dulbecco's modified essential medium (DMEM) containing 17% fetal bovine serum (FBS) for 24 hours, after which the medium was changed to 5% FBS and normal glucose (NG) (5.5mmol/L), high glucose (HG) (30mmol/L), or normal glucose plus 30mmol/L mannitol (NGM) were added. The media was changed every 2 days to maintain the appropriate concentrations of glucose or mannitol. At the times indicated, cell viability was measured in an MTS assay. (B) Lactate dehydrogenase (LDH) release into the media by human mesangial cells treated with normal glucose or high glucose. (C) Western blots for the active fragments of human caspase-3 (p17 and p19 kD) in human mesangial cells incubated with normal glucose or high glucose. (D) Densitometric analysis of the combined p17 and p19 caspase-3 levels from three experiments. (E) Photomicrograph illustrating morphology of pyknotic nuclei (arrows) (i.e., nuclear condensation and segmentation) revealed by Hoechst 33342 staining in human mesangial cells treated with high glucose for 48 hours (magnification ×600). (F) Percentage of pyknotic nuclei identified in human mesangial cells incubated with normal glucose or high glucose. (A, B, and D) are mean ± SEM from three independent experiments. *P < 0.05; **P < 0.01 by t test vs. normal glucose at same time point. (F) Three experiments. **P < 0.01 by χ2 test vs. normal glucose. Kidney International 2005 67, 82-93DOI: (10.1111/j.1523-1755.2005.00058.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 2 High glucose stimulates caspase-9 cleavage in cultured human mesangial cells. (A) Human mesangial cells treated with normal glucose (NG) or high glucose (HG) were harvested, and equivalent amounts of cell protein (P) were analyzed by Western blotting for the cleaved (C) fragments of human caspase-9 (p35 kD) and caspase-8 (p40 kD). (B) Densitometric analysis of active caspase-9 fragment levels in Western blots from three independent experiments. **P < 0.01 by t test vs. normal glucose at same time point. Kidney International 2005 67, 82-93DOI: (10.1111/j.1523-1755.2005.00058.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 3 High glucose increases caspase-9 enzyme activity in human mesangial cells. Cells incubated in high glucose (HG) for the times indicated were lysed, and caspase-9 enzyme activity (i.e., LEHDase activity) was measured using equivalent amounts of human mesangial cell protein. Enzyme activity measured as relative light units was normalized relative to caspase-9 activity at 0 time in normal glucose. *P < 0.05; **P < 0.01 by one-way analysis of variance (ANOVA) with Bonferroni post hoc test vs. control (three independent experiments in duplicate). Kidney International 2005 67, 82-93DOI: (10.1111/j.1523-1755.2005.00058.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 4 High glucose elevates cytosolic levels of cytochrome-c in human mesangial cells. (A) Translocation of p14 kD cytochrome-c to the cytosol was measured by Western blotting of cells fractionated into cytosol (top panel) and membrane-bound (bottom panel) preparations by digitonin. Equivalent amounts of either the cytosol or membrane-bound fractions from cells treated with normal glucose (NG) or high glucose (HG) were loaded in each lane. (B) Densitometric analysis of p14 cytochrome-c levels in cytosolic fractions from three independent experiments. **P < 0.01 by t test vs. normal glucose at same time. Kidney International 2005 67, 82-93DOI: (10.1111/j.1523-1755.2005.00058.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 5 Inhibition of caspase-9 blocks apoptosis induced by high glucose in cultured human mesangial cells. (A) Cells were treated for 24 hours with normal glucose (NG) or high glucose (HG) in the absence or presence of 40 μmol/L Z-LEHD-FMK to inhibit caspase-9 (C9I). The levels of p17 and p19 kD cleaved caspase-3 (upper panel) were measured by Western blotting. Inhibition of caspase-3 cleavage by Z-LEHD-FMK was observed in two independent experiments. (B) Human mesangial cells treated with high glucose as in (A) were fixed, stained with Hoechst 33342, and the percentage of pyknotic nuclei were counted. **P < 0.01 by χ2 test. Kidney International 2005 67, 82-93DOI: (10.1111/j.1523-1755.2005.00058.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 6 Caspases-3 and -7 are activated specifically in db/db kidneys. (A) Kidney extracts containing equal amounts of protein were analyzed by Western blotting for caspase-3 activation using an antibody that recognizes a “neoepitope” in the cleaved (C) 19 kD murine casapse-3 active fragment. To determine if caspase-7 was activated in db/db kidneys, we performed Western blots with an anticleaved caspase-7 (Asp198) antibody that detects endogenous levels of the large active fragment (p 20 kD) of caspase-7 resulting from cleavage at aspartic acid 198. This antibody does not crossreact with full-length caspase-7 or with other caspases. The blot was reprobed with an antibody that recognizes β-actin to confirm equal protein loading (bottom panel). Two different mouse kidney extracts have been presented at each time point (lanes 1 and 2). (B) Densitometric analysis of Western blots for the active caspase-7 fragment in extracts prepared from five mice per condition. **P < 0.01 by one-way analysis of variance (ANOVA) with Bonferroni post hoc test vs. db/m. Kidney International 2005 67, 82-93DOI: (10.1111/j.1523-1755.2005.00058.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 7 Caspase-9 is activated in db/db diabetic kidneys. (A) Kidneys from db/db and db/m kidneys were homogenized, and equivalent amounts of tissue protein were analyzed by Western blotting. Specific antibodies were used that recognize the procaspase (P) and cleaved (C) forms of murine caspase-9, murine caspase-8, and murine caspase-12. β-actin was used as a control for protein loading. The position and molecular weight of the procasapse and cleaved caspase are indicated. Each lane represents a different mouse kidney extract from each group (i.e., lanes 1 and 2). (B) Densitometric analysis of the active caspase-9 fragment by Western blots performed on five mice per condition. **P < 0.01 by one-way analysis of variance (ANOVA) with Bonferroni post hoc test vs. db/m. Kidney International 2005 67, 82-93DOI: (10.1111/j.1523-1755.2005.00058.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 8 Bax protein is specifically elevated in the diabetic compared to the nondiabetic kidneys. (A) Equivalent amounts of kidney protein were analyzed for Bax by Western blotting. The antibody specifically recognizes the full-length p20 kD protein, which was elevated in the diabetic kidneys. Modest levels of p20 were observed in the 8- and 16-week db/m kidneys but were always lower than levels in the corresponding db/db mice. Lanes 1 and 2 represent two different mice in each condition. (B) Densitometric analysis of p20 Bax levels from a total of five mice in each group. **P < 0.01 by one-way analysis of variance (ANOVA) with Bonferroni post hoc test vs. db/m. Kidney International 2005 67, 82-93DOI: (10.1111/j.1523-1755.2005.00058.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 9 Localization of apoptotic cells to the glomeruli of 16-week db/db mice Representative hematoxylin-eosin staining of (A) 16-week db/m nondiabetic control kidney and (B) 16-week db/db diabetic kidneys. The magnified insets from (A) and (B) are shown in (C) and (D), respectively. Histologic hallmarks of apoptosis, including condensation of nuclear chromatin and segmentation of the nuclei (D, arrows), were evident in glomeruli of db/db kidneys but not in the db/m controls. Terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate (dUTP) nick end labeling (TUNEL) identifies DNA fragmentation, an important characteristic of apoptotic cells, and is evident in glomeruli of 16-week db/db glomeruli (E and F, arrows). The TUNEL-stained sections were counterstained with methyl green. (G) TACS-nuclease-treated controls were performed in each assay to confirm sufficient permeabilization as were (F) unlabeled experimental controls [i.e., omission of terminal deoxynucleotidyl transferase (TdT)]. Both (G and H) are representative glomeruli from 16-week db/db mice. All measurements of TUNEL staining in db/db kidneys were conducted concurrently with identically processed db/m controls (magnification ×400). Kidney International 2005 67, 82-93DOI: (10.1111/j.1523-1755.2005.00058.x) Copyright © 2005 International Society of Nephrology Terms and Conditions